Home/Filings/4/0001217234-23-000028
4//SEC Filing

Seeto Reginald 4

Accession 0001217234-23-000028

CIK 0001217234other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 9:47 PM ET

Size

19.0 KB

Accession

0001217234-23-000028

Insider Transaction Report

Form 4
Period: 2023-02-01
Seeto Reginald
See Remarks
Transactions
  • Award

    Common Stock

    2023-02-01+302,000569,152 total
  • Sale

    Common Stock

    2023-02-02$17.50/sh503$8,805575,803 total
  • Tax Payment

    Common Stock

    2023-02-02$17.61/sh7,244$127,567568,559 total
  • Tax Payment

    Common Stock

    2023-02-03$16.54/sh1,228$20,311566,103 total
  • Tax Payment

    Common Stock

    2023-02-01$15.66/sh2,330$36,488578,622 total
  • Sale

    Common Stock

    2023-02-02$17.07/sh2,316$39,542576,306 total
  • Award

    Stock Option (right to buy)

    2023-02-01+156,000156,000 total
    Exercise: $15.66Exp: 2033-02-01Common Stock (156,000 underlying)
  • Award

    Common Stock

    2023-02-01+11,800580,952 total
  • Tax Payment

    Common Stock

    2023-02-03$16.54/sh1,228$20,311567,331 total
Footnotes (8)
  • [F1]The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 1, 2024 and 1/4th of which shall vest on each anniversary thereafter.
  • [F2]Includes 177 shares acquired on January 2, 2023 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
  • [F3]The reported securities were subject to a performance restricted stock unit award that was initially granted on February 3, 2021 for a two-year performance period over calendar years 2021 and 2022, which performance was assessed and finalized effective February 1, 2023. 50.00% of the reported securities vested on February 1, 2023 and 50% of the reported securities will vest on December 31, 2023, subject to the Reporting Person's continued service with the Issuer.
  • [F4]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
  • [F5]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $17.34, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.44 to $17.61, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  • [F8]1/4th of the shares subject to the option shall vest on February 2, 2024 and 1/48th of the shares subject to the option shall vest monthly thereafter.

Issuer

CareDx, Inc.

CIK 0001217234

Entity typeother

Related Parties

1
  • filerCIK 0001688485

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 9:47 PM ET
Size
19.0 KB